SCHEMBL5151189

SCHEMBL5151189

CC(C)c1cccc(-c2ccccc2C(=O)O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.58
RXRB P28702 1/20 0.58
RXRG P48443 1/20 0.58
UCHL5 Q9Y5K5 1/20 0.50
NR4A2 P43354 1/20 0.49
HNF4A P41235 1/20 0.49
ADRB2 P07550 1/20 0.48
ADRB1 P08588 1/20 0.48
ADRB3 P13945 1/20 0.48
MYC P01106 1/20 0.47
NOTUM Q6P988 1/20 0.47
DHODH Q02127 1/20 0.46
CTSA P10619 2/20 0.44
PTPN5 P54829 2/20 0.44
ALDH1A1 P00352 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12543763 0.86 BCAT2 (0.59) RXRARXRBRXRGNR4A2CTSA
SCHEMBL689031 0.82 HNF4A (0.62) UCHL5HNF4AMYCALDH1A1L3MBTL1
SCHEMBL10415503 0.82 RXRA (0.59) RXRARXRBRXRGNR4A2HNF4A
SCHEMBL4741406 0.81 DHODH (0.56) HNF4AMYCDHODHL3MBTL1LMNA
SCHEMBL9177215 0.80 RXRA (0.50) RXRARXRBRXRGNR4A2PTPN5
SCHEMBL25598368 0.80 RXRA (0.54) RXRARXRBRXRGNR4A2NOTUM
Hydrochloric Acid SCHEMBL5937171 0.80 DHODH (0.55) HNF4AMYCDHODHL3MBTL1LMNA
SCHEMBL20173747 0.80 RXRA (0.49) RXRARXRBRXRGHNF4ANOTUM
SCHEMBL11416615 0.80 RXRA (0.61) RXRARXRBRXRGNR4A2HNF4A
SCHEMBL6499038 0.80 FOLH1 (0.53) RXRARXRBRXRGDHODHLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 RXRA 1528/4885RXRB 648/4885RXRG 2311/4885
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R RXRA 1256/4885RXRB 1669/4885RXRG 1191/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.